Last €129.51 EUR
Change Today +1.44 / 1.12%
Volume 2.2M
As of 3:45 PM 01/26/15 All times are local (Market data is delayed by at least 15 minutes).

bayer ag-reg (BAYN) Snapshot

Open
€127.20
Previous Close
€128.07
Day High
€129.91
Day Low
€127.00
52 Week High
01/26/15 - €129.91
52 Week Low
04/15/14 - €89.49
Market Cap
107.1B
Average Volume 10 Days
2.9M
EPS TTM
€4.42
Shares Outstanding
826.9M
EX-Date
04/30/14
P/E TM
29.3x
Dividend
€2.10
Dividend Yield
1.62%
Current Stock Chart for BAYER AG-REG (BAYN)

bayer ag-reg (BAYN) Related Bloomberg News

View More Bloomberg News

bayer ag-reg (BAYN) Details

Bayer Aktiengesellschaft develops, produces, and markets health care and agricultural products, and high-tech polymer materials worldwide. The company operates through HealthCare, CropScience, and MaterialScience segments. The HealthCare segment offers prescription pharmaceuticals, such as contraceptives, hemophilia treatments, anticoagulants, and medicines to treat multiple sclerosis, cancer, hypertension, and infectious diseases; and consumer health products comprising over-the-counter medications, dermatology products, nutritional supplements, veterinary medicines, and animal grooming products. This segment also provides medical care products, including blood glucose monitoring devices, such as single-strip and multi-strip systems; USB meters that feature integrated diabetes management software and direct plug-in to computers; contrast agent injection systems for diagnostic and therapeutic medical procedures in computed tomography, magnetic resonance imaging, and molecular imaging; and mechanical systems for removing thrombi from blood vessels, as well as service products for its systems. The CropScience segment offers products for use in agriculture as insecticides, fungicides, and herbicides or seed treatments; seeds and plant traits; and various products for gardens, green industry, and nonagricultural pest control. The MaterialScience segment provides high-tech polymer materials in the areas of polyurethanes, polycarbonates, coating and adhesive raw materials, and functional films; and produces and markets inorganic basic chemicals. The company has a strategic alliance with OncoMed Pharmaceuticals, Inc. to develop drugs to target cancer stem cell therapeutics. Bayer Aktiengesellschaft was founded in 1863 and is headquartered in Leverkusen, Germany.

107,700 Employees
Last Reported Date: 02/28/14
Founded in 1863

bayer ag-reg (BAYN) Top Compensated Officers

Chairman of Management Board and Chief Execut...
Total Annual Compensation: €2.9M
Chief Strategy & Portfolio Officer and Member...
Total Annual Compensation: €1.8M
Labor Director and Member of Management Board
Total Annual Compensation: €1.1M
Compensation as of Fiscal Year 2013.

bayer ag-reg (BAYN) Key Developments

Bayer AG Presents at Commerzbank German Investment Seminar, Jan-12-2015

Bayer AG Presents at Commerzbank German Investment Seminar, Jan-12-2015 . Venue: New York, New York, United States.

Bayer Names Steven Immergut as New Head of Communications for its Pharmaceutical Business

Bayer has appointed Steven Immergut as new head of communications for its pharmaceutical business in the US. Steven Immergut has been hired in the newly created role of VP, head of pharmaceutical communications where he will lead the design, management and execution of the company's external and internal communications in the region.

Proteros Signs Research Cooperation Agreement with Bayer

Proteros announced that it signed a research cooperation agreement with Bayer aimed at identifying new agents for the treatment of cardiovascular diseases. Under the agreement, Proteros will be carrying out the research on a regulating membrane protein over a period of two years in order to achieve defined milestones, while Bayer will be responsible for the optimisation of pre-clinical candidates and clinical development. Proteros will receive payments for its R&D activities as well as milestone payments and royalties from the sale of potential commercial products.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
BAYN:GR €129.51 EUR +1.44

BAYN Competitors

Market data is delayed at least 15 minutes.

Company Last Change
AbbVie Inc $62.83 USD +0.40
Amgen Inc $159.73 USD -0.08
Celgene Corp $124.12 USD +0.23
Sanofi €82.95 EUR -0.63
Siemens AG €103.05 EUR +2.42
View Industry Companies
 

Industry Analysis

BAYN

Industry Average

Valuation BAYN Industry Range
Price/Earnings 25.7x
Price/Sales 2.3x
Price/Book 4.7x
Price/Cash Flow 25.7x
TEV/Sales 1.9x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact BAYER AG-REG, please visit www.bayer.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.